Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Open-label Multicenter Dose Escalation and Dose Expansion Study to Evaluate the Safety and Efficacy of KLS-1 as Monotherapy in Patients With Malignant Neoplasms

NCT06506643 is registered in ClinicalTrials.gov with Vector Vitale LLC as lead sponsor.

NCT NCT06506643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06506643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Open-label Multicenter Dose Escalation and Dose Expansion Study to Evaluate the Safety and Efficacy of KLS-1 as Monotherapy in Patients With Malignant Neoplasms
Lead sponsor
Vector Vitale LLC
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 15, 2024
Completion date
December 31, 2029
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cll, solid tumor, adult